Overview

Effects of Drospirenone Versus Non-hormonal Contraceptive Methods on Bone Mineral Density in Adolescent and Adult Women

Status:
Not yet recruiting

Trial end date:
2027-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the impact of LF111 (drospirenone) on bone mineral density at the lumbar spine after 12 months (13 medication cycles) of investigation in comparison to non-hormonal contraceptive methods.

Phase:

Phase 4

Details

Lead Sponsor:

Insud Pharma

Collaborator:

Chemo Research

Treatments:

Drospirenone